Stock Market News
U.S. FTC launches inquiry into drug middlemen
2022.06.07 21:15
FILE PHOTO: Signage is seen at the Federal Trade Commission headquarters in Washington, D.C., U.S., August 29, 2020. REUTERS/Andrew Kelly
(Reuters) – The Federal Trade Commission said on Tuesday it will launch an inquiry into the prescription drug middleman industry, sending compulsory orders to six pharmacy benefit managers for records on their business practices.
As part of the inquiry, the antitrust body will send orders to CVS Health Corp (NYSE:CVS)’s Caremark, Humana Inc (NYSE:HUM), Cigna Corp (NYSE:CI)’s Express Scripts (NASDAQ:ESRX) and UnitedHealth Group (NYSE:UNH)’s OptumRx, among others.
